ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 142 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $796,000 | +9.0% | 42,209 | -31.9% | 0.00% | 0.0% |
| Q2 2019 | $730,000 | -13.1% | 62,015 | +0.7% | 0.00% | 0.0% |
| Q1 2019 | $840,000 | +37.3% | 61,559 | +3.1% | 0.00% | 0.0% |
| Q4 2018 | $612,000 | -41.0% | 59,717 | -4.2% | 0.00% | 0.0% |
| Q3 2018 | $1,038,000 | +1.4% | 62,339 | -3.8% | 0.00% | 0.0% |
| Q2 2018 | $1,024,000 | +32.1% | 64,815 | +6.2% | 0.00% | 0.0% |
| Q1 2018 | $775,000 | -3.0% | 61,022 | -12.6% | 0.00% | 0.0% |
| Q4 2017 | $799,000 | +90.7% | 69,804 | +104.1% | 0.00% | – |
| Q3 2017 | $419,000 | -18.8% | 34,194 | -24.1% | 0.00% | -100.0% |
| Q2 2017 | $516,000 | +26.5% | 45,060 | +129.5% | 0.00% | 0.0% |
| Q1 2017 | $408,000 | -28.4% | 19,635 | -28.3% | 0.00% | 0.0% |
| Q4 2016 | $570,000 | -73.8% | 27,382 | -58.7% | 0.00% | -66.7% |
| Q3 2016 | $2,175,000 | +29.0% | 66,369 | -1.7% | 0.00% | 0.0% |
| Q2 2016 | $1,686,000 | +68.9% | 67,504 | +65.7% | 0.00% | +50.0% |
| Q1 2016 | $998,000 | +121.3% | 40,737 | +198.1% | 0.00% | +100.0% |
| Q4 2015 | $451,000 | – | 13,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
| Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
| DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
| Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
| Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
| Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
| Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
| Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
| Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |